We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$517B
AUM Growth
+$27.6B
Cap. Flow
-$8.37B
Cap. Flow %
-1.62%
Top 10 Hldgs %
19.4%
Holding
4,590
New
277
Increased
1,772
Reduced
2,129
Closed
201

Top Sells

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$692M
2
LIN icon
Linde
LIN
+$624M
3
MDT icon
Medtronic
MDT
+$527M
4
GS icon
Goldman Sachs
GS
+$340M
5
MSFT icon
Microsoft
MSFT
+$301M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 13.18%
3 Financials 12.45%
4 Consumer Discretionary 10.8%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OIG
4176
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$59K ﹤0.01%
337
WTT
4177
DELISTED
Wireless Telecom Group, Inc.
WTT
$58K ﹤0.01%
14,217
LNAI
4178
Lunai Bioworks
LNAI
$10.5M
$57K ﹤0.01%
142
-508
-78% -$166K
FRTX
4179
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$57K ﹤0.01%
1,341
CASI
4180
DELISTED
CASI Pharmaceuticals
CASI
$56K ﹤0.01%
3,644
-15,141
-81% -$255K
COCP icon
4181
Cocrystal Pharma
COCP
$15.2M
$56K ﹤0.01%
3,710
CPIX icon
4182
Cumberland Pharmaceuticals
CPIX
$118M
$56K ﹤0.01%
19,843
SINT icon
4183
SiNtx Technologies
SINT
$10.2M
$56K ﹤0.01%
1
VIRC icon
4184
Virco
VIRC
$95.6M
$56K ﹤0.01%
16,543
AVGR
4185
DELISTED
Avinger, Inc. Common Stock
AVGR
$56K ﹤0.01%
153
STCN
4186
DELISTED
Steel Connect, Inc. Common Stock
STCN
$55K ﹤0.01%
2,940
CRTO icon
4187
Criteo S.A. Ordinary Shares
CRTO
$892M
$54K ﹤0.01%
1,202
+159
+15% +$6.12K
IZEA icon
4188
IZEA Worldwide
IZEA
$53.6M
$54K ﹤0.01%
5,313
PAYS icon
4189
Paysign
PAYS
$729M
$54K ﹤0.01%
17,054
-99,598
-85% -$358K
AIM
4190
AIM ImmunoTech
AIM
$7.1M
$54K ﹤0.01%
253
CKPT
4191
DELISTED
Checkpoint Therapeutics
CKPT
$53K ﹤0.01%
1,785
-10,272
-85% -$285K
DVD
4192
DELISTED
Dover Motorsports
DVD
$52K ﹤0.01%
23,305
+1
+0% +$2
BCDA icon
4193
BioCardia
BCDA
$13.7M
$51K ﹤0.01%
857
-156
-15% -$9.47K
JAGX icon
4194
Jaguar Health
JAGX
$3.68M
0
NXE icon
4195
NexGen Energy
NXE
$6.97B
$51K ﹤0.01%
12,478
CFMS
4196
DELISTED
Conformis, Inc. Common Stock
CFMS
$51K ﹤0.01%
1,766
GIFI
4197
DELISTED
Gulf Island Fabrication
GIFI
$50K ﹤0.01%
11,069
BIOR
4198
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$50K ﹤0.01%
56
-107
-66% -$81.8K
LOGC
4199
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$49K ﹤0.01%
10,930
-43,068
-80% -$219K
KUST
4200
Kustom Entertainment Inc
KUST
$809K
0

Similar funds

Bank of New York Mellon's Q2 2021 Portfolio in Review

As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
  • Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
  • Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
  • Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
  • Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
  • Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
  • Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.